---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-25-011834"
form_type: "8-K"
ticker: "IRMD"
cik: "0001325618"
company_name: "IRADIMED CORP"
filed_at: "2025-09-02T23:59:59+00:00"
generated_at: "2026-05-17T08:45:11.108453+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Iradimed appoints Masimo founder Joe Kiani to board; Anthony Vuoto retires

## Summary
- Anthony Vuoto retired as director effective Aug 27, 2025; no disagreement with the company.
- Joe Kiani, founder of Masimo and CEO of Willow Laboratories, appointed director effective Sep 2, 2025.
- Kiani will serve on the Audit Committee and chair the Compensation Committee.
- Board size remains at five directors after the transition.
- Kiani receives standard non-employee director compensation as disclosed in the 2025 proxy.

## SEC filing metadata
- accession: 0001558370-25-011834
- form_type: 8-K
- ticker: IRMD
- cik: 0001325618
- company_name: IRADIMED CORP
- filed_at: 2025-09-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1325618/000155837025011834/0001558370-25-011834-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1325618/000155837025011834/irmd-20250827x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-25-011834
- JSON: https://secwatch.observer/filing/0001558370-25-011834.json
- Plain text: https://secwatch.observer/filing/0001558370-25-011834.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.